AACI Commentary

About Our Editorial Series

Exploring Topics of Interest to AACI Cancer Centers

To promote the work of its member centers, AACI publishes Commentary, an editorial series focusing on major issues of common interest to North American cancer centers. 

Each AACI Commentary is written by a cancer center leader or subject matter expert and distributed by email to nearly 3,000 readers of the AACI Update newsletter. 

The publication is designed to cover a specific topic in 750-1,000 words. Recommendations for topics and authors are encouraged. 

Please submit suggestions to: 

Chris Zurawsky
Director of Communications and Public Affairs

Emily Stimmel
Communications and External Relations Manager

July 2021

A “Delicate Dance”
Establishing a Process for Assessing and Endorsing Cancer-Related Policy

By John DeMuro

When it comes to appropriations and legislation that directly impact scientific policy, AACI cancer centers face a dilemma. Although cancer centers may choose to collaborate with elected officials to enact specific priorities, these priorities may be at odds with the overall scientific direction and funding decisions of government agencies including the National Institutes of Health (NIH) and National Cancer Institute (NCI).

From the perspective of these agencies, legislative language that is overly directive may be perceived as minimizing the peer review process in identifying promising opportunities.

Furthermore, due to finite financial resources, existing priorities may go under- or unfunded. However, some legislative initiatives have enormous potential to accelerate progress against cancer, reduce cancer mortality, and boost investments in the research conducted at cancer centers. Their value to the cancer center network cannot be understated.

Read the July 2021 Commentary.

Zip Code vs. Genetic Code: Breaking Down Cancer Disparities in Philadelphia
By Karen E. Knudsen, PhD
October 2017

Satisfaction with Oncology Quality and Clinical Operations: A survey from the AACI Physician Clinical Leadership Initiative (PCLI)
By Morgan Dodson, Michael Neuss, Laura Hutchins, Richard Lauer, John Sweetenham, Nathan Levitan, Martha Mims, Mohammed Milhem, Craig Bunnell, Dan Mulkerin, Randall F. Holcombe
Fall 2017

SF CAN: A City Working Together to Fight Cancer 
By Alan Ashworth, PhD, FRS
Summer 2017

Integrating Clinical Research into Clinical Care
By Martha Mims, MD, PHD & Sarah McNees, PHD
Spring 2017